Purchases and Sales Made in Q1 2024 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q1 2024. The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 08, 2024
Q1 2024
|
State Board Of Administration Of Florida Retirement System
|
SELL
|
- |
-1.4K- 6.97% |
$1.29K - $2.02K
|
18.7K
$71K
|
|
Apr 29, 2024
Q1 2024
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-1.77K- 9.09% |
$1.62K - $2.54K
|
17.7K
$67.1K
|
|
May 15, 2024
Q1 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-1.79K- 2.76% |
$1.64K - $2.57K
|
63K
$239K
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4.48K- 45.95% |
$4.12K - $6.45K
|
5.27K
$20K
|
|
Nov 14, 2024
Q1 2024
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-5.7K- 31.31% |
$5.25K - $8.21K
|
12.5K
$47.6K
|
|
Apr 23, 2024
Q1 2024
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-7.49K- 76.45% |
$6.89K - $10.8K
|
2.31K
$8.77K
|
|
May 10, 2024
Q1 2024
|
Vontobel Holding Ltd.
|
SELL
|
- |
-10.3K- 33.92% |
$9.45K - $14.8K
|
20K
$76K
|
|
May 08, 2024
Q1 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-17K- 3.9% |
$15.6K - $24.5K
|
419K
$1.59M
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-20.4K- 87.32% |
$18.8K - $29.4K
|
2.97K
$11.3K
|
|
May 15, 2024
Q1 2024
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-22.7K- 28.39% |
$20.8K - $32.6K
|
57.1K
$217K
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-30.1K- 19.63% |
$27.7K - $43.4K
|
123K
$469K
|
|
May 06, 2024
Q1 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-30.4K- 8.87% |
$28K - $43.8K
|
313K
$1.19M
|
|
May 14, 2024
Q1 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-40.2K- 80.67% |
$37K - $58K
|
9.65K
$36.7K
|
|
May 15, 2024
Q1 2024
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-48.6K- 87.43% |
$44.7K - $70K
|
6.98K
$26.5K
|
|
Apr 25, 2024
Q1 2024
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-49.6K- 17.57% |
$45.6K - $71.4K
|
233K
$885K
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-50K- 3.6% |
$46K - $72K
|
1.34M
$5.09M
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-73K- 4.18% |
$67.2K - $105K
|
1.67M
$6.36M
|
|
May 15, 2024
Q1 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-90.4K- 66.81% |
$83.2K - $130K
|
44.9K
$171K
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-97.4K- 14.77% |
$89.6K - $140K
|
562K
$2.14M
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-98.5K- 52.51% |
$90.6K - $142K
|
89.1K
$338K
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-99.7K- 79.55% |
$91.8K - $144K
|
25.6K
$97.5K
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-108K- 61.19% |
$99K - $155K
|
68.3K
$259K
|
|
May 15, 2024
Q1 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-134K- 9.15% |
$123K - $193K
|
1.33M
$5.05M
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-206K- 5.92% |
$189K - $296K
|
3.27M
$12.4M
|
|
May 10, 2024
Q1 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-216K- 9.19% |
$199K - $311K
|
2.14M
$8.11M
|
|
May 15, 2024
Q1 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-245K- 8.17% |
$225K - $353K
|
2.75M
$10.5M
|
|
May 13, 2024
Q1 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-255K- 67.46% |
$235K - $367K
|
123K
$468K
|
|
May 13, 2024
Q1 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-273K- 62.12% |
$251K - $393K
|
167K
$633K
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-375K- 72.01% |
$345K - $540K
|
146K
$554K
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-468K- 27.84% |
$430K - $673K
|
1.21M
$4.61M
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-484K- 49.62% |
$445K - $697K
|
492K
$1.87M
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-484K- 49.62% |
$445K - $697K
|
492K
$1.87M
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
SELL
|
- |
-495K- 97.57% |
$456K - $713K
|
12.3K
$46.9K
|
|
May 15, 2024
Q1 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-500K- 14.29% |
$460K - $720K
|
3M
$11.4M
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-704K- 11.92% |
$647K - $1.01M
|
5.2M
$19.8M
|
|
May 03, 2024
Q1 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-909K- 57.23% |
$836K - $1.31M
|
679K
$2.58M
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-4.46M- 82.74% |
$4.1M - $6.42M
|
930K
$3.53M
|